<DOC>
	<DOCNO>NCT01997294</DOCNO>
	<brief_summary>Statins approve benefit patient underwent percutaneous coronary intervention ( PCI ) . The current study design evaluate effectiveness safety Sequential Therapy Atorvastatin patient ST-elevated myocardial infarction receive PCI treatment .</brief_summary>
	<brief_title>Sequential Therapy Atorvastatin Improve Outcomes ST-elevated Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Sighed inform consent Diagnosised acute myocardial infarction Time frame le 12 hour since occurance chest pain Aggred receive sirolimuseluted coronary stent Patients willing accepte followup Allegy statins history statin therapy Allegy product use PPCI Disagreed receive PPCI related therapy Existing sever liver dysfuntion statin use accord guildlines Sever kidney dysfunction ( creatinine &gt; 3mg/dl eGFR &lt; 30ml/min ) Sever leave ventricular dysfunction ( Killip grade 3 ) Patients currently take medicine may influence use statin Patients history alcohol abuse durg abuse Woman pregnancy lactation Patients attend clinical trial Patients receive PCI CABG previously Patients agree accept study protocol Other condition may sutible current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>sequential therapy</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>